Evidence map›Paper›PMID 25075743›Full record

ArticlePloS one2014

Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.

Eduard Eduardo, Matthew R Lamb, Sasi Kandula, Andrea Howard, Veronicah Mugisha, Davies Kimanga, Bonita Kilama, Wafaa El-Sadr, Batya Elul

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Growing older with HIV in the Treat-All Era.Journal of the International AIDS Society · 2022
    Article
  8. Observational
  9. Article
  10. Article
  11. Sex Differences in the Treatment of HIV.Current HIV/AIDS reports · 2020
    Review
  12. Article
  13. Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans.European journal of drug metabolism and pharmacokinetics · 2019
    Observational
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eduard EduardoDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Matthew R LambDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Sasi KandulaICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Andrea HowardDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Veronicah MugishaICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Davies KimangaNational AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya.
Bonita KilamaNational AIDS Control Program, Ministry of Health and Social Welfare, Dar es Salaam, Tanzania.
Wafaa El-SadrDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Batya ElulDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America.

Funding

NCHHSTP CDC HHS U2G PS001537PHS HHS 5U2GPS001537-03
6 · The paper itself

Abstract

backgroundLimited information exists on adults ≥50 years receiving HIV care in sub-Saharan Africa. METHODOLOGY: Using routinely-collected longitudinal patient-level data among 391,111 adults ≥15 years enrolling in HIV care from January 2005-December 2010 and 184,689 initiating ART, we compared characteristics and outcomes between older (≥50 years) and younger adults at 199 clinics in Kenya, Mozambique, Rwanda, and Tanzania. We calculated proportions over time of newly enrolled and active adults receiving HIV care and initiating ART who were ≥50 years; cumulative incidence of loss to follow-up (LTF) and recorded death one year after enrollment and ART initiation, and CD4+ response following ART initiation.

findingsFrom 2005-2010, the percentage of adults ≥50 years newly enrolled in HIV care remained stable at 10%, while the percentage of adults ≥50 years newly initiating ART (10% [2005]-12% [2010]), active in follow-up (10% [2005]-14% (2010]), and active on ART (10% [2005]-16% [2010]) significantly increased. One year after enrollment, older patients had significantly lower incidence of LTF (33.1% vs. 32.6%[40-49 years], 40.5%[25-39 years], and 56.3%[15-24 years]; p-value<0.0001), but significantly higher incidence of recorded death (6.0% vs. 5.0% [40-49 years], 4.1% [25-39 years], and 2.8% [15-24 years]; p-valve<0.0001). LTF was lower after vs. before ART initiation for all ages, with older adults experiencing less LTF than younger adults. Among 85,763 ART patients with baseline and follow-up CD4+ counts, adjusted average 12-month CD4+ response for older adults was 20.6 cells/mm3 lower than for adults 25-39 years of age (95% CI: 17.1-24.1).

conclusionsThe proportion of patients who are ≥50 years has increased over time and been driven by aging of the existing patient population. Older patients experienced less LTF, higher recorded mortality and less robust CD4+ response after ART initiation. Increased programmatic attention on older adults receiving HIV care in sub-Saharan Africa is warranted.

Indexed as

AdolescentAdultAmbulatory Care FacilitiesAnti-HIV AgentsCD4 Lymphocyte CountFemaleGovernment ProgramsHIV InfectionsHumansKenyaLost to Follow-UpMaleMiddle AgedMozambiqueRwandaTanzaniaAnti-HIV Agents

Identifiers

PMID25075743
PMCPMC4116238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.